GRCE
Grace Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $2.12
- As of
Share the GRCE intelligence card
See GRCE live in the terminal
Track GRCE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live GRCE terminal, freeActive signals for GRCE
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +727% to GRCE (2026Q2)
- mediumNEW_POSITION
TWO SIGMA INVESTMENTS, LP new position in GRCE
- mediumNEW_POSITION
TWO SIGMA INVESTMENTS, LP new position in GRCE
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +88% to GRCE (2026Q1)
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 74.4% - EPS $-0.06 vs $-0.2346 estimate
FREE, NO ACCOUNT
Every signal on GRCE, as it fires
You are seeing 5 of 9 signals recorded on GRCE since 2026-05-30.
The five above landed across 3 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Top institutional holders of GRCE (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $1.1M | 0.00% | +87.9% |
| RENAISSANCE TECHNOLOGIES LLC | $449K | 0.00% | +53.5% |
| RENAISSANCE TECHNOLOGIES LLC | $252K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $220K | 0.00% | , |
| CITADEL ADVISORS LLC | $148K | 0.00% | +55.1% |
| CITADEL ADVISORS LLC | $119K | 0.00% | , |
| CITADEL ADVISORS LLC | $81K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, GRCE
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more GRCE signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GRCEand get the insider, 13F, options, and confluence read in one view.